Takeda (ADR)
Develops prescription medicines across gastrointestinal disease, rare disease, plasma therapies, oncology, neuroscience, and vaccines.
$18.49
After-hours close+0.46 (+2.53%)
At close$18.03(0.00%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 3.30%Insiders —
Shares outstanding 3.18B · Float 3.16B · 99.2% free float
Insiders — filings are in the shares behind the receipt.
This listing is a depositary receipt and the Form 4 positions here are filed in the shares behind it, a different unit from the share count and in a ratio the filings never state, so no insider percentage is shown.
Institutions13F, as of Jun 30, 2026
385 holders · 104.85M shares · 71 new positions · 212 increased · 101 reduced · 53 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Capital Research Global Investors | 19.30M | 0.61% | +193.5K | Aug 12, 2026 |
| FMR LLC | 9.60M | 0.30% | +2.48M | Aug 13, 2026 |
| Morgan Stanley | 6.99M | 0.22% | +525.3K | Aug 13, 2026 |
| Adage Capital Partners GP, L.L.C. | 6.05M | 0.19% | −374.2K | Aug 14, 2026 |
| Goldman Sachs Group Inc | 5.13M | 0.16% | −493.7K | Aug 14, 2026 |
| Brandes Investment Partners, LP | 4.54M | 0.14% | +108.7K | Aug 14, 2026 |
| Arrowstreet Capital, Limited Partnership | 3.73M | 0.12% | +616.6K | Aug 13, 2026 |
| BlackRock, Inc. | 3.69M | 0.12% | +511.7K | Aug 7, 2026 |
Beneficial owners13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
InsidersForm 4
| Insider | Role | Shares | Filed |
|---|---|---|---|
| Andrew Stewart Plump | director, officer: President, R&D | 1.03M | Aug 21, 2026 |
| Christophe Pierre Weber | director, officer: President and CEO | 418.8K | Apr 28, 2026 |
| Julie So-Young Kim | director, officer: President and CEO | 391.5K | Aug 12, 2026 |
| Giles Richard Platford | officer: President, IBU | 315.8K | Aug 12, 2026 |
| Teresa Marie Bitetti | officer: President, OBU | 252.0K | Aug 12, 2026 |
| Lauren Rusckowski Duprey | officer: Chief Transformation Officer | 226.1K | Aug 12, 2026 |
| Natalie Anne Marie Furney | officer: Global General Counsel | 204.3K | Aug 12, 2026 |
| Rhonda Janice Pacheco | officer: President, U.S. Business Unit | 182.5K | Aug 12, 2026 |
| Agosti Marcello Pignagnoli | officer: Head, Strat. & Port. Dev | 177.0K | Aug 12, 2026 |
| Gabriele Ricci | officer: Chief Data & Tech. Officer | 171.7K | Aug 12, 2026 |
16 positions are filed in the unlisted share unit (1.25M shares), which no share count here divides
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 19, 2026 | Andrew Stewart Plumpdirector, officer: President, R&D | Sale | 19,651 | $18.49 | 261,656 |
| Aug 18, 2026 | Nicola Deidre Petal Greenwayofficer: Chief Human Resources Officer | Sale | 12,980 | $18.11 | 40,049 |
| Aug 10, 2026 | Rhonda Janice Pachecoofficer: President, U.S. Business Unit | Sale | 16,901 | $17.10 | 182,507 |
| Aug 10, 2026 | Ramy Riad Ahmed Ibrahimofficer: President, PDT BU | Sale | 7,277 | $17.10 | 102,588 |
| Aug 10, 2026 | Awny Samaan Botros Farajallahofficer: Chief Medical Officer | Sale | 14,006 | $17.10 | 116,177 |
| Aug 10, 2026 | Andrew Stewart Plumpdirector, officer: President, R&D | Sale | 165,393 | $17.10 | 766,569 |
| Aug 10, 2026 | Lauren Rusckowski Dupreyofficer: Chief Transformation Officer | Sale | 47,586 | $17.10 | 226,057 |
| Aug 10, 2026 | Teresa Marie Bitettiofficer: President, OBU | Sale | 50,012 | $17.10 | 252,010 |
| Aug 10, 2026 | Agosti Marcello Pignagnoliofficer: Head, Strat. & Port. Dev | Sale | 22,957 | $17.10 | 176,977 |
| Aug 10, 2026 | Elaine Mary Shannonofficer: Pres., Global Supply & Quality | Sale | 3,978 | $17.10 | 63,333 |
CongressHouse and Senate disclosures
Not reported.